Europe’s antitrust enforcer hit Google with another massive fine on Wednesday, this time a €4.34 billion ($5.04 billion) levy over the licensing practices for its Android mobile operating system, nearly double one issued last year for favoring its own comparison shopping site in search results. Here, Law360 takes a look at the latest fine and what it could mean for Google.
Grocery giants The Kroger Co., Hy-Vee Inc. and Albertsons Cos. Inc. are the latest to accuse Tyson and other chicken producers of an alleged conspiracy to fix broiler chicken prices, with the grocers filing suit over the claims in Illinois federal court on Friday.
A defunct Illinois drug distribution company filed putative class antitrust allegations against Novartis Pharmaceuticals Corp. and Par Pharmaceutical Inc. on Friday, alleging in New York federal court that the pair cooked up a pay-for-delay scheme for Novartis' high blood pressure drug Exforge.
Democratic Sens. Cory Booker and Elizabeth Warren on Thursday urged the U.S. Department of Justice and the Federal Trade Commission to rethink their “safety zone” for allowing employers to share detailed wage information without violating antitrust laws.
President Donald Trump said Friday he will announce his nominee to take Justice Anthony Kennedy’s place on the U.S. Supreme Court on July 9, and that he has narrowed down the pool of candidates to “around” five people, including two women.
Fenwick & West LLP, Dechert LLP, Holland & Hart LLP, Carlton Fields, Aerie Pharmaceuticals Inc. and Milberg Tadler Phillips Grossman LLP have grown their health and life sciences abilities with attorneys from White & Case LLP, Simpson Thacher & Bartlett LLP, Stoel Rives LLP, Polsinelli PC, Sanofi and Girard Gibbs LLP.
Justice Anthony M. Kennedy, the longest-serving active member of the U.S. Supreme Court, announced his retirement Wednesday after three decades on the high court. Here, Law360 analyzes his immense impact and what his departure means for the future of the court.
The last week has seen more than a dozen U.K. municipal authorities lodge a derivatives suit against Barclays, a hedge fund accuse Portugal's Novo Banco of tripping a default for billions of euros worth of debt and a dispute between a unit of troubled specialty reinsurer CBL Corp. and one of its former originating insurers.
AbbVie Inc. and an affiliate must pay $448 million in the Federal Trade Commission’s suit alleging they netted more than $1 billion after bringing sham patent lawsuits to stave off generic competition to AbbVie’s AndroGel testosterone replacement drug, a Pennsylvania federal court ruled Friday.
Two Democratic House Reps from California have asked the Federal Communications Commission when it will decide whether to reconsider Liberman Broadcasting's petition accusing Comcast of stifling competition by allowing Estrella TV to be dropped from certain markets after the two telecoms could not agree on carriage talks.
A trade association for Broadway theater workers has dropped a lawsuit accusing several casting companies and New York's Teamsters Union of forming a cartel, after months of settlement negotiations, the group has told a New York federal judge.
A former partner at Willkie Farr & Gallagher LLP and Hunton & Williams LLP was disbarred in New York on Thursday after pleading guilty to a $7.8 million wire fraud scheme in which she billed her former employers and MasterCard Inc. for work that was never performed.
Associate Justice Anthony Kennedy spent his three decades on the high court making a name for himself as a champion of individual freedoms, but he also authored the majority opinion in Ashcroft v. Iqbal that changed corporate litigation so much, it is cited in nearly every dismissal bid and has become the bane of the plaintiffs bar.
The U.K. competition authority said Thursday it has asked to appeal a tribunal’s decision ordering it to take a second look at a case wherein the watchdog slapped Pfizer and Flynn Pharma with a £89.4 million ($116.9 million) fine after finding excessive and unfair pricing of an anti-epilepsy drug.
The retirement of Justice Anthony Kennedy means that Chief Justice John Roberts is now the U.S. Supreme Court's most important member not just in title but also in reality, empowering him to advance a muscular conservative agenda and perhaps broker deals with outgunned liberals.
The Federal Communications Commission’s administrative law judge system is one of the easiest ways to strangle a proposed media merger, Commissioner Michael O'Rielly suggested Thursday, saying in a speech that the agency’s in-house review process should be scrapped.
Smartphone consumers urged a California federal judge Thursday to prevent Qualcomm's attempt to force Apple to only import iPhones with Qualcomm chipsets, saying the chipmaker must face their antitrust multidistrict litigation over its patent licensing practices first.
Nonprofit groups Public Knowledge and Common Cause on Thursday told the Federal Communications Commission to wait before deciding if Sinclair Broadcast Group Inc. can merge with Tribune Media Co. until after the D.C. Circuit has looked at whether the agency's viewership discounts under its UHF rule are lawful.
High-ranking Republicans on the Senate Judiciary Committee stood firm Thursday on keeping Majority Leader Mitch McConnell's promise to vote this fall on a replacement for retiring U.S. Supreme Court Justice Anthony Kennedy, with one saying Democrats' calls to wait until after the November midterms "ain't going to happen."
In his three decades on the high court, Justice Anthony Kennedy authored opinions that changed the rules for federal civil litigation, opened the floodgates for corporations and unions to fund campaign advertisements, and reshaped the legal landscape for women and same-sex couples.
President Donald Trump made it clear Wednesday that the world already knows the name of the person he is going to nominate to replace retiring Associate Justice Anthony M. Kennedy. The question is, which name will it be?
The Serious Fraud Office has landed another mixed result in its prosecution of several former Barclays and Deutsche Bank traders for manipulating Euribor, the latest in the white collar specialist's latest effort to hold individuals accountable for rigging key benchmark interest rates. Here, Law360 looks at the highlights of the SFO's long-running campaign.
A D.C. federal judge has rejected the U.S. Department of Justice’s arguments that AT&T’s planned purchase of Time Warner would hurt competition and drive up consumer costs, dealing a major blow to the government’s first court challenge of a vertical merger in decades. Here, Law360 looks at how we got here, the key issues and highlights of the case.
The latest ABA annual antitrust law spring meeting ran the gamut from the government's tough new take on no-poaching pacts to hurdles innovation can cause in merger reviews— plus wide-ranging comments from the DOJ's new antitrust chief. Here's a look at Law360's coverage of three days of debates, tips and quips.
An Alabama federal court recently ruled that it is per se anti-competitive for the Blue Cross and Blue Shield Association to grant licenses to member plans to use trademarks in exclusive geographic markets. If upheld, this decision represents a significant threat to the fundamental structure of the association, says Robert Craig of Taft Stettinius & Hollister LLP.
A controversial issue argued Tuesday before the U.S. Supreme Court was whether the Second Circuit should have given complete deference to a declaration that price-fixing by two vitamin C manufacturers was required by Chinese law. When a foreign government’s regulation is exempt, measuring damages attributable only to the cartel respects international comity while also recognizing how foreign cartels can harm U.S. customers, say members of Monument Economics Group.
In recent weeks, regional transmission organizations have attempted to amend their Federal Energy Regulatory Commission tariffs to protect their energy and capacity markets from state subsidies for certain types of power generation. Such subsidies challenge FERC’s authority to effectively operate competitive wholesale markets, says Richard Drom of Eckert Seamans Cherin & Mellott LLC.
In presenting the core tenets of the “New Brandeis movement,” a recent article in the Journal of European Competition Law & Practice exposes a flawed understanding of the relation between anti-monopoly and American democracy, confirms concerns that this movement heralds a return to “big is bad,” and misconstrues the Chicago School’s intellectual foundations, says Joseph Coniglio of Wilson Sonsini Goodrich & Rosati PC.
It's been eight years since the U.S. Supreme Court’s ruling in Shady Grove Orthopedic Associates v. Allstate Insurance, but courts continue to wrestle with whether state statutory class action bars are enforceable in federal court, say Daniel Fong and Robert Guite of Sheppard Mullin Richter & Hampton LLP.
High prescription drug prices are increasingly a focal point in the discussion of U.S. health care spending. While there is little consensus in Congress, there has been considerable recent activity in the federal executive branch and in state legislatures, say Tom Bulleit and Rebecca Williams of Ropes & Gray LLP.
With Federal Trade Commissioner Terrell McSweeny resigning soon, acting Chairman Maureen Ohlhausen could become the sole commissioner. The FTC seems to think it can act by a 1-0 vote, but this may be unlawful and is certainly unwise, say Stephen Calkins of Wayne State University and John Villafranco of Kelley Drye & Warren LLP.
Among the proposed amendments to Rule 23 of the Federal Rules of Civil Procedure, which are scheduled to take effect Dec. 1, are specific requirements related to “front-loading.” They outline the process for seeking preliminary court approval of class action settlements and related notice plans, say Shandarese Garr and Niki Mendoza of Garden City Group LLC.
The past few years have seen a resurgence in the acquisition of physician practices, both by hospitals and by private equity firms. However, acquiring a physician group carries special challenges in view of the heavy regulation of the health care provider industry, says William Eck of Seyfarth Shaw LLP.
It is a safe bet that the U.S. Department of Justice is poised to sign on to the European agreement on Bayer’s acquisition of rival Monsanto, perhaps with a few tweaks. Even so, the Bayer-Monsanto transaction is likely to harm U.S. farmers, say Allen Grunes and Maurice Stucke, founders of The Konkurrenz Group.